Fundraising FoxBeiGene
Venture capitalChangping · Series A–Series B · 38 people tracked
Find your way into BeiGene
Sign up to see every warm intro you have to BeiGene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BeiGene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BeiGene (branded as BeOne) is a global biotechnology/pharmaceutical company that develops and commercializes cancer treatments and other medicines, not a venture capital investor.
Source: firm website, verified Aug 16, 2026.
Team · 38 people
from the firm's website
Anthony Hooper is the retired executive vice president of Amgen Inc. and serves as an independent director for BeiGene Ltd., MannKind Corporation, Amplity Health, and Lykan Biosciences. He is a board member of the American Institute of Stuttering, where he received the "2008 Freeing Voices, Changing Lives" Award alongside Joe Biden, and the Impact Young Lives Foundation. Hooper holds law and MBA degrees from the University of South Africa.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does BeiGene invest at?
- BeiGene invests at the Series A, Series B stages.
- What sectors does BeiGene focus on?
- BeiGene focuses on Biotech, Healthtech.
- Where is BeiGene located?
- BeiGene is headquartered in Changping, CN.
Media · Podcasts & interviews
featuring the teamBeiGene CEO John V. Oyler's Welcome Remarks on BeiGene Virtual Congress Site
BeiGene · John V. Oyler
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.